| Literature DB >> 17438518 |
Wing Chun Tang1, Shea Ping Yip, Ka Kin Lo, Po Wah Ng, Pik Shan Choi, Sau Yin Lee, Maurice K H Yap.
Abstract
PURPOSE: To test the association between myocilin gene (MYOC) polymorphisms and high myopia in Hong Kong Chinese by using family-based association study.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17438518 PMCID: PMC2652017
Source DB: PubMed Journal: Mol Vis ISSN: 1090-0535 Impact factor: 2.367
Figure 1The structure of the MYOC gene and the locations of genetic markers tested in the study. Microsatellites were named according to The GDB Human Genome Database and single nucleotide polymorphisms with rs numbers. Their positions are indicated according to the recommendations of the Human Genome Variation Society (nomenclature for the description of sequence variations).
Genotyping of MYOC microsatellites and single nucleotide polymorphisms.
| NGA17 | MS/Fragment analysis | Myocpm-F | FLU-GGCTGTTATTTTTCTCTGT |
| Myocpm-R | TGCCAGCAAGATTCTTAGAA | ||
| NGA19 | MS/Fragment analysis | Myoc3pm-F | FLU-GTTGGGAGATGTGATTGCAG |
| Myoc3pm-R | AGATGGAGGTGGGAAAGTGT | ||
| rs7523603 | SNP/TaqMan Assay-by-Design | Myocil-F | CGGACCCAGAGCGAAGTT |
| Myocil-R | AGGGCTGTGGAAAGGTTATGG | ||
| A allele-specific probe | VIC-CTGTGAGGTCAC[A]GAAG-MGB | ||
| G allele-specific probe | FAM-TGTGAGGTCAC[G]GAAG-MGB | ||
| rs2075537 | SNP/TaqMan Assay-on-Demand | C_27532255_10 | T (VIC) and G (FAM) |
| rs235920 | SNP/TaqMan Assay-on-Demand | C_558534_10 | T (VIC) and C (FAM) |
| rs2421853 | SNP/TaqMan Assay-on-Demand | C_11335131_10 | A (VIC) and G (FAM) |
| rs235858 | SNP/TaqMan Assay-on-Demand | C_2964922_10 | A (VIC) and G (FAM) |
Forward primers that amplified microsatellites (MS) were labeled with fluorescein (FLU). Four single nucleotide polymorphisms (SNPs) were genotyped by assay-on-demand TaqMan. Only assay identifications and allele-specific probe signals were provided by the manufacturer. All allele-specific probes were labeled with a reporter dye (either VIC or FAM) at the 5' end, and a quencher and a minor groove-binder (MGB) at the 3' end. Bases in square brackets indicate the positions of the bases defining the alleles of the SNPs that were to be detected by the probes.
Summary of ocular data of myopic offspring.
| Spherical power (D) | -8.38±1.90 | -8.27±1.89 |
| Equivalent spherical power (D) | -9.06±2.01 | -9.10±2.00 |
| Astigmatism (D) | -1.35±0.88 | -1.67±0.96 |
| Corneal cylindrical power (D) | -1.54±0.73 | -1.65±0.79 |
| Axial length (mm) | 26.88±1.05 | 26.86±1.14 |
| Anterior chamber depth (mm) | 3.57±0.34 | 3.54±0.35 |
This study involved a total of 233 myopic offspring. The table shows the distribution of refractive errors and size-related measurements of both eyes in the myopic offspring. All ocular data are expressed as mean±standard deviation. D represents diopters.
MYOC polymorphisms: summary of genetics data for parents and tests of association by family-based association testing under different genetic models in 162 nuclear families.
| Allele | 1 (G) | 2 (T) | 3 (13) | 4 (14) | 5 (15) | 6 (16) | 1 (T) | 2 (C) | 1 (A) | 2 (G) | ||||
| Freq in parents | 0.5633 | 0.4367 | 0.5015 | 0.1836 | 0.3117 | 0.0031 | 0.5355 | 0.4645 | 0.7562 | 0.2438 | ||||
| FBAT - Additive model | ||||||||||||||
| No. of families | 125 | 125 | 123 | 74 | 107 | 2 | 121 | 121 | 91 | 91 | ||||
| Z score | -0.45 | 0.45 | 1.34 | 1.56 | -2.59 | - | -1.09 | 1.09 | 1.21 | -1.21 | ||||
| p value | 0.6526 | 0.6526 | 0.1797 | 0.12 | 0.0097 | - | 0.2774 | 0.2774 | 0.2283 | 0.2283 | ||||
| Global stat. | chi2(1)=0.203 | chi2(3)=11.733 | chi2(1)=1.180 | chi2(1)=1.452 | ||||||||||
| p=0.6526 | p=0.0084 | p=0.2774 | p=0.2283 | |||||||||||
| FBAT - Dominant model | ||||||||||||||
| No. of families | 70 | 95 | 82 | 73 | 94 | 2 | 79 | 88 | 32 | 78 | ||||
| Z score | -0.21 | 0.45 | 0.87 | 1.46 | -2.47 | - | -0.97 | 0.7 | 1.65 | -0.52 | ||||
| p value | 0.8316 | 0.6528 | 0.3843 | 0.1455 | 0.01443 | - | 0.3316 | 0.4838 | 0.09945 | 0.6004 | ||||
| Global stat. | chi2(2)=0.225 | chi2(3)=7.366 | chi2(2)=1.243 | chi2(2)=2.85 | ||||||||||
| p=0.8934 | p=0.0611 | p=0.5372 | p=0.2405 | |||||||||||
| FBAT - Recessive model | ||||||||||||||
| No. of families | 95 | 70 | 83 | 18 | 38 | 0 | 88 | 79 | 78 | 32 | ||||
| Z score | -0.45 | 0.21 | 1.17 | 0.76 | -1.19 | - | -0.7 | 0.97 | 0.52 | -1.65 | ||||
| p value | 0.6528 | 0.8316 | 0.2438 | 0.4477 | 0.233 | - | 0.4838 | 0.3316 | 0.6004 | 0.0995 | ||||
| Global stat. | chi2(2)=0.225 | chi2(3)=3.212 | chi2(2)=1.243 | chi2(2)=2.85 | ||||||||||
| p=0.8934 | p=0.3601 | p=0.5372 | p=0.2405 | |||||||||||
| Allele | 1 (11) | 3 (13) | 4 (14) | 5 (15) | 6 (16) | 7 (17) | 1 (C) | 2 (T) | 1 (T) | 2 (C) | ||||
| Freq in parents | 0.0015 | 0.2176 | 0.0077 | 0.7114 | 0.0602 | 0.0015 | 0.7299 | 0.2701 | 0.6003 | 0.3997 | ||||
| FBAT - Additive model | ||||||||||||||
| No. of families | 1 | 96 | 5 | 115 | 32 | 1 | 102 | 102 | 109 | 109 | ||||
| Z score | - | -3.03 | - | 2.1 | 1.13 | - | -3.32 | 3.32 | 4.6 | -4.6 | ||||
| p value | - | 0.0024 | - | 0.0353 | 0.2579 | - | 0.0009 | 0.0009 | 0.000004 | 0.000004 | ||||
| Global stat. | chi2(3)=10.162 | chi2(1)=11 | chi2(1)=21.146 | |||||||||||
| p=0.0172 | p=0.0009 | p=4.0E-6 | ||||||||||||
| FBAT - Dominant model | ||||||||||||||
| No. of families | 1 | 91 | 5 | 42 | 32 | 1 | 26 | 95 | 54 | 87 | ||||
| Z score | - | -2.28 | - | 2.83 | 0.93 | - | -1.8 | 2.97 | 2.92 | -3.9 | ||||
| p value | - | 0.0224 | - | 0.0047 | 0.3519 | - | 0.0725 | 0.003 | 0.0035 | 0.000096 | ||||
| Global stat. | chi2(3)=12.711 | chi2(2)=11.011 | chi2(2)=21.165 | |||||||||||
| p=0.0053 | p=0.0041 | p=2.5E-5 | ||||||||||||
| FBAT - Recessive model | ||||||||||||||
| No. of families | 0 | 28 | 0 | 107 | 1 | 0 | 95 | 26 | 87 | 54 | ||||
| Z score | - | -2.53 | - | 0.92 | - | - | -2.97 | 1.8 | 3.9 | -2.92 | ||||
| p value | - | 0.0113 | - | 0.3576 | - | - | 0.003 | 0.0725 | 0.000096 | 0.0035 | ||||
| Global stat. | chi2(2)=6.837 | chi2(2)=11.011 | chi2(2)=21.165 | |||||||||||
| p=0.0328 | p=0.0041 | p=2.5E-5 | ||||||||||||
The polymorphisms are shown in order from the 5' end to the 3' end of the MYOC gene: the first four markers in the top part and the last three markers in the bottom part (See Figure 1 for details). For single nucleotide polymorphisms, the major allele was designated as 1 and minor allele as 2, with the identities of the alleles shown within brackets. For microsatellites, four alleles were found for NGA17 and six alleles for NGA19, with the number of GT repeats shown within brackets. "No. of families" refers to the number of informative families in which there was at least one heterozygous parent while "-" indicates that the corresponding value was not calculated because the number of informative families was less than 10. The degree of freedom (n) is shown within brackets after chi2: χ2(n), where n=1, 2, or 3.
Figure 2Pairwise measures of linkage disequilibrium (D' and r2) for MYOC markers under study. The cells below the diagonally descending shaded boxes show the D' (top) and r2 (bottom and in brackets) values. The cells above the shaded boxes show the exact p values for the corresponding linkage disequilibrium measurements.
Estimates of genotype relative risks based on case-pseudocontrol data using the GenAssoc package.
| rs2421853 | C/C | 1 | - | - | - | 9.00E-04 |
| C/T | 1.678 | 3.19 | 0.0014 | 1.222-2.308 | ||
| T/T | 2.738 | 2.76 | 0.0057 | 1.340-5.593 | ||
| rs235858 | C/C | 1 | - | - | - | 2.00E-06 |
| C/T | 2.083 | 3.13 | 0.0017 | 1.316-3.298 | ||
| T/T | 3.931 | 5.01 | 5.50E-07 | 2.301-6.717 | ||
The table shows the effect sizes of the genotypes in terms of genotype relative risk (GRR) and the corresponding 95% confidence intervals (CI). For each genotype, the Z score is the statistic testing the deviation of the GRR from 1 and the significance level as the p value. For each SNP, the significance of the global Wald test is indicated in the last column. Robust variance estimates were used to account for correlation between contributions from nuclear families with two or more siblings.
Wald test of main effects in a forward stepwise regression analysis of case-pseudocontrol dataset.
| NGA17 | NGA17 + NGA19 | 4.79 | 2 | 0.0914 |
| NGA17 | NGA17 + rs2421853 | 11.33 | 2 | 0.0035 |
| NGA17 | NGA17 + rs235858 | 18.43 | 2 | 0.0001 |
| NGA19 | NGA19 + NGA17 | 5.3 | 2 | 0.0706 |
| NGA19 | NGA19 + rs2421853 | 10.13 | 2 | 0.0063 |
| NGA19 | NGA19 + rs235858 | 22.61 | 2 | 1.20E-05 |
| rs2421853 | rs2421853 + NGA17 | 3.64 | 2 | 0.1622 |
| rs2421853 | rs2421853 + NGA19 | 3.86 | 2 | 0.1455 |
| rs2421853 | rs2421853 + rs235858 | 17.88 | 2 | 0.0001 |
| rs235858 | rs235858 + NGA17 | 0.52 | 2 | 0.771 |
| rs235858 | rs235858 + NGA19 | 4 | 2 | 0.1355 |
| rs235858 | rs235858 + rs2421853 | 6.36 | 2 | 0.0415 |
| rs2421853 + rs235858 | rs2421853 + rs235858 + NGA17 | 0.79 | 2 | 0.674 |
| rs2421853 + rs235858 | rs2421853 + rs235858 + NGA19 | 4.11 | 2 | 0.1283 |
| rs2421853 + rs235858 | rs2421853 + rs235858 + NGA17 + NGA19 | 5.08 | 2 | 0.2789 |
For NGA17 and NGA19, the case-pseudocontrol dataset was generated after grouping all non-5 alleles into one allele.